tiprankstipranks
Advertisement
Advertisement

MIRA Stock Latest News

MIRA Pharmaceuticals announces positive preclinical results for MIRA-55
Company AnnouncementsMIRA Pharmaceuticals announces positive preclinical results for MIRA-55
1d ago
8K
MIRA
Mira Pharmaceuticals reports formulation results for MIRA-55
PremiumThe Fly
Mira Pharmaceuticals reports formulation results for MIRA-55
2d ago
MIRA
MIRA Reports Positive Preclinical Data for SKNY-1 Program
PremiumCompany Announcements
MIRA Reports Positive Preclinical Data for SKNY-1 Program
5d ago
8K
MIRA
Mira Pharmaceuticals reports SKNY-1 formulation results
PremiumThe Fly
Mira Pharmaceuticals reports SKNY-1 formulation results
5d ago
MIRA
MIRA Unveils Differentiated Preclinical Data for Mira-55
PremiumCompany Announcements
MIRA Unveils Differentiated Preclinical Data for Mira-55
16d ago
8K
MIRA
Mira Pharmaceuticals reports preclinical pharmacology data on Mira-55
PremiumThe FlyMira Pharmaceuticals reports preclinical pharmacology data on Mira-55
17d ago
MIRA
Psychedelic: Clearmind completes Part A dosing for Phase I/II CMND-100 trial
Premium
The Fly
Psychedelic: Clearmind completes Part A dosing for Phase I/II CMND-100 trial
23d ago
CMND
JAGX
MIRA Advances Ketamir-2 Into FDA-Accepted Phase 2a Trial
Premium
Company Announcements
MIRA Advances Ketamir-2 Into FDA-Accepted Phase 2a Trial
24d ago
8K
MIRA
Mira Pharmaceuticals submits Phase 2a trial protocol to U.S. FDA for Ketamir-2
PremiumThe Fly
Mira Pharmaceuticals submits Phase 2a trial protocol to U.S. FDA for Ketamir-2
24d ago
MIRA
Psychedelic: Optimi Health completes psilocybin export to the UK
PremiumThe Fly
Psychedelic: Optimi Health completes psilocybin export to the UK
1M ago
IXHL
MIRA
MIRA Pharmaceuticals Appoints New Fractional Chief Financial Officer
PremiumCompany Announcements
MIRA Pharmaceuticals Appoints New Fractional Chief Financial Officer
1M ago
8K
MIRA
Psychedelic: Enveric initiates IND-enabling genotoxicity studies of EB-003
PremiumThe Fly
Psychedelic: Enveric initiates IND-enabling genotoxicity studies of EB-003
1M ago
CMND
ENVB
MIRA Pharmaceuticals Secures Unified Global Rights to Pipeline
PremiumCompany AnnouncementsMIRA Pharmaceuticals Secures Unified Global Rights to Pipeline
1M ago
8K
MIRA
Mira Pharmaceuticals secures worldwide rights to MIRA-55, SKNY-1
Premium
The Fly
Mira Pharmaceuticals secures worldwide rights to MIRA-55, SKNY-1
1M ago
MIRA
Psychedelic: Optimi Health advances natural psilocybin extract
Premium
The Fly
Psychedelic: Optimi Health advances natural psilocybin extract
1M ago
CMND
CMPS
Mira Pharmaceuticals secures worldwide rights for Ketamir-2
PremiumThe Fly
Mira Pharmaceuticals secures worldwide rights for Ketamir-2
2M ago
MIRA
MIRA Expands Global Ketamir-2 License for Clinical Development
PremiumCompany Announcements
MIRA Expands Global Ketamir-2 License for Clinical Development
2M ago
8K
MIRA
Mira Pharmaceuticals management to meet with Maxim
PremiumThe Fly
Mira Pharmaceuticals management to meet with Maxim
2M ago
MIRA
Psychedelic: Compass Pathways, AtaiBeckley, GH Research report earnings
PremiumThe Fly
Psychedelic: Compass Pathways, AtaiBeckley, GH Research report earnings
2M ago
ATAI
CMND
Mira announces results from Phase 1 trial evaluating Ketamir-2
PremiumThe FlyMira announces results from Phase 1 trial evaluating Ketamir-2
2M ago
MIRA
MIRA Pharmaceuticals Reports Positive Phase 1 Ketamir-2 Results
Premium
Company Announcements
MIRA Pharmaceuticals Reports Positive Phase 1 Ketamir-2 Results
2M ago
8K
MIRA
Mira announces acceptance of peer-reviewed SKNY-1 manuscript
Premium
The Fly
Mira announces acceptance of peer-reviewed SKNY-1 manuscript
2M ago
MIRA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >